NCT03113240View on ClinicalTrials.gov

Trial of Enteral Glutamine on Intestinal Permeability in Critically Ill Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

October 1, 2017

Study Completion Date

October 1, 2017

Conditions
Critical IllnessEnteral NutritionIntestinal Permeability
Interventions
DRUG

Glutamin

Enteral Glutamine 0.3g/kg/day powdered glutamine to be mixed in with water and given via nasogastric tube q4 hrs.

OTHER

Maltodextrin

Maltodextrin mixed with water given via NG tube q 4 hours.

Trial Locations (1)

Unknown

Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Shohada Tajrish Hospital, Tehran

All Listed Sponsors
lead

Shahid Beheshti University

OTHER

NCT03113240 - Trial of Enteral Glutamine on Intestinal Permeability in Critically Ill Patients | Biotech Hunter | Biotech Hunter